Reversed-phase high-performance liquid chromatography (RP-HPLC) remains the dominant separation mode in pharmaceutical and biomedical analysis, yet method development is still largely driven by trial-and-error practices, fragmented literature knowledge, or data-intensive chemometric tools. Despite decades of accumulated chromatographic experience, this knowledge is rarely transferred in a form that enables rapid, rational, and reproducible decision-making at the early stages of method development. This Perspective introduces Method-at-a-Glance (MAG), a conceptual, literature-encoded graphical framework that reimagines RP-HPLC method development as a visually guided process grounded in collective chromatographic knowledge. By abstracting and mapping reported chromatographic conditions for structurally related pharmaceutical classes, MAG enables the rapid identification of rational starting conditions, significantly reducing the scope of preliminary experimentation. Rather than proposing a new analytical method, this Perspective synthesizes the existing literature into a transferable visual intelligence tool and discusses its implications for accelerating method development, improving reproducibility, and reducing experimental burden. The broader opportunities of MAG are explored, including its potential role in AI-assisted chromatography and sustainability-oriented analytical design. MAG exemplifies how analytical chemistry can move beyond the isolated method reporting toward knowledge-integrated, concept-driven frameworks that support the evolving needs of modern laboratories.
Hamed et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: